Sign In

In 2017, AASLD Foundation is helping bring 60 promising early-career investigators to The Liver Meeting® to attend and present their work to an international audience.

Congratulations to the 2017 Abstract Award recipients. These awardees will present their research at The Liver Meeting® in Washington, DC October 20-24.

Advanced Practice Providers Travel Award (2 awards)

These $1,000 awards enable mid-level professionals submitting abstracts for The Liver Meeting® to receive travel support.

  • Amanda Chaney, DNP, ARNP, FNP-BC, FAANP
    Institution: Mayo Clinic Jacksonville
    Abstract: Benefit of Supplemental Nutrition Education for Severely Malnourished Cirrhotic Patients
  • Crystal David, PharmD
    Institution: Oklahoma State University Center for Health Sciences
    Abstract: Hepatitis C treatment outcomes in a pharmacist-managed clinic in a rural tribal health system

Basic Science Young Investigator Travel Awards (20 awards)

These $1,000 awards recognize outstanding young basic science researchers submitting abstracts to The Liver Meeting®.

  • Cristina Alarcon-Vila, PhD
    Institution: Institute of Biomedical Research of Barcelona (IIBB-CSIC)
    Abstract: Acute-on-chronic alcoholic steatohepatitis and fibrosis in FRGN mice with humanized liver
  • Michele Alves-Bezerra, PhD
    Institution: Weill Cornell Medical College
    Abstract: Responding to metabolic demand: Key role for Thioesterase superfamily member 2 in the hepatic partitioning of fatty acids between oxidative and synthetic pathways
  • Saisakul Chernbumroong, PhD
    Institution: University of Nottingham
    Abstract: Advanced machine learning techniques to identify a panel of biomarkers that identify nonalcoholic steatohepatitis
  • Romain Desert, PharmD, PhD
    Institution: University of Illinois at Chicago
    Abstract: Hepatocyte-derived Osteopontin drives the development of Hepatocellular Carcinoma
  • Istvan Furi, PharmD, PhD
    Institution: University of Massachusetts Medical School Department of Medicine
    Abstract: Exosome biogenesis in alcoholic liver disease: Dumping out trash or strategic sorting in miR-155 dependent autophagy induction and alcohol-induced exosome release?
  • Petra Hirsova, PhD
    Institution: Mayo Clinic Rochester
    Abstract: TRAIL Deletion Prevents Liver, but Not Adipose Tissue, Inflammation during Murine Diet-Induced Obesity
  • Dagmar Kollmann, MD, PhD
    Institution: Toronto General Hospital
    Abstract: Normothermic ex vivo liver perfusion prevents platelet sequestration and platelet induced sinusoidal cell injury in the liver after liver transplantation
  • Enis Kostallari, PhD
    Institution: Mayo Clinic
    Abstract: SHP2 promotes liver fibrosis by inducing secretion of hepatic stellate cell-derived PDGFRα-enriched extracellular vesicles
  • Supriya Kulkarni, MS, PhD
    Institution: Yale University
    Abstract: Deficiency of bile acid transporter Ostα alters plasma oxysterol mediated Lxrα/β signaling and lipid accumulation in mouse adipose
  • Sebastian Larion, MD
    Institution: Augusta University / Medical College of Georgia
    Abstract: Nox1 as a Novel Source of Hepatic Oxidant Stress during Obesity to Promote Lipotoxicity in Humans and Mice with Non-alcoholic Fatty Liver Disease
  • Zhipeng Li, PhD
    Institution: Mayo Clinic Rochester
    Abstract: A Novel and Direct Interaction Between Large and Small GTPases Mediates Autophagic Lipid Droplet Breakdown in Hepatocytes
  • Xiaojiaoyang Li, BS
    Institution: Virginia Commonwealth University
    Abstract: LncRNAH19-containing exosomes from cholangiocytes promote cholestatic liver injury in Mdr2 knock out mice
  • Hyuk Moon
    Institution: Yonsei University College of Medicine
    Abstract: Development of mouse models for hepatocellular carcinoma and intrahepatic cholangiocarcinoma induced by activated TAZ
  • Takuto Nosaka, MD
    Institution: University of Fukui
    Abstract: Leukotriene B4 Generated by Alveolar Macrophages Drive Hepatocellular Carcinoma Lung Metastasis
  • Núria Pell, PhD student
    Institution: IDIBAPS (Institut d'Investigacions Biomèdiques Pi i Sunyer)
    Abstract: Gene therapy with endothelial-specific liposomal short interfering siRNA targeting kinase insert domain receptor inhibits portosystemic collateralization in portal hypertension
  • Sadatsugu Sakane MD
    Institution: Osaka University Graduate School of Medicine
    Abstract: Autophagic changes of both adipose tissues and the liver induced by high fat diet feeding contribute to hepatic lipid accumulation
  • Keisaku Sato, PhD
    Institution: Texas A&M Health Science Center
    Abstract: Anti-inflammatory effects of miR-21 depletion in the macrophage response to cholestatic liver injury
  • Kai Markus Schneider, MD
    Institution: University Hospital RWTH Aachen
    Abstract: NLRP6 inflammasome-mediated dysbiosis augments acetaminophen induced acute liver injury
  • Hong Shen, MS
    Institution: Guangdong Hospital of Traditional Chinese Medicine in Zhuhai
    Abstract: Role of Intestine-Specific Sirt1 in the Protective Action of Salvianolic Acid B against Ethanol-Induced Inflammation and Liver Injury in Mice
  • Muhammed Yuksel
    Institution: Institute of Liver studies, King's College Hospital London
    Abstract: Association between disease-predisposing HLA DR3/DR7/DR13 genes with numeric impairment of immunoregulatory T-cells in patients with autoimmune hepatitis/sclerosing cholangitis

Fellow Research Award (1 award)

This $1,000 award is given for the best abstract submitted by a fellow to The Liver Meeting®.

  • Anand V. Kulkarni, MD, DNB, DM
    Institution: Institute of Liver and Biliary Sciences
    Abstract: ω3 polyunsaturated fatty acids(PUFA) lipid emulsions are safe and effective to reduce endotoxemia and sepsis in patients with Acute on Chronic Liver Failure -A randomised controlled trial.(NCT 02691533)

International Young Investigator Travel Awards (5 awards)

These $1,500 awards provide travel support to young international researchers submitting abstracts for The Liver Meeting®.

  • Sumeet Kainth, MD, DM
    Institution: Institute of Liver and Biliary Sciences
    Abstract: Efficacy And Safety Of Carvedilol In Patients Of Acute-On-Chronic Liver Failure With Small Or No Esophageal Varices – A Placebo Control Open Label Randomised Trial (NCT02583698)
  • Leandro Mendes MD
    Institution: State University of Campinas, Brazil
    Abstract: Controlled Attenuation Parameter (CAP) diagnostic performance in Vibration Controlled Transient Elastography (Fibroscan®) for steatosis staging in comparison to direct quantification through digital morphometric analysis of liver biopsy
  • Fakhar Ali Qazi Arisar, FCPS
    Institution: The Aga Khan University Hospital, Karachi
    Abstract: Multidimensional burden of disease in chronic liver disease patients
  • Lin Wang, MD, PhD
    Institution: Fourth Military Medical University, Xijing Hospital
    Abstract: Endothelium derived Notch signal promotes liver sinusoidal endothelial cell senescence and blunts angiocrine to hamper liver regeneration in an eNOS-Wnt2a dependent manner
  • Yusuke Watanabe
    Institution: Niigata University
    Abstract: Live image and mechanistic analysis of Mesenchymal stem cells (MSCs) and induced bone marrow derived macrophages (id-BMMs) combination therapy for liver cirrhosis in mice

Liver Transplant and/or Hepatobiliary Surgery Fellow Awards (2 awards)

These $1,000 travel awards enable liver transplant and/or hepatobiliary surgery fellows submitting abstracts for The Liver Meeting® to receive travel support.

  • Yuri Boteon, MD
    Institution: National Institute for Health Research (NIHR) Birmingham Liver Biomedical Research Unit
    Abstract: The Efficacy of Pharmacological Intervention for Reducing Macrovesicular Lipid Accumulation in Primary Human Hepatocytes In Vitro: A Precursor Study to Improvement of Macrovesicular Steatosis in Donor Livers with Normothermic Machine Perfusion of the Liver
  • Bettina M. Buchholz, MD, FEBS
    Institution: Liver Unit, Queen Elizabeth Hospital Birmingham
    Abstract: New insights from the SILVER study; a 50 % reduction in Calcineurin Inhibitors at day 30 does not impact on long-term renal function after liver transplantation

Pediatric Research Award (1 award)

The purpose of this $1,000 award is to foster excellence in pediatric liver disease research. The award is given to a physician/scientist with a primary appointment affiliation in a department of pediatrics.

  • Susan M. Siew, MBBS (Hons.) FRACP PhD
    Institution: The Children's Hospital at Westmead
    Abstract: Long-Term Disease Correction and Reduced Liver Tumorigenesis Using Hybrid Recombinant AAV-Piggybac Transposon Mediated Gene Therapy in the Progressive Familial Intrahepatic Cholestasis Type 3 (PFIC3) Mouse Model in vivo

PSC Partners Seeking a Cure Award for the Most Promising PSC Research (1 award)

The annual award of $3,000 is given to the investigator presenting the most promising PSC research at The Liver Meeting®.

  • Mark Deneau, MD, MS
    Institution: University of Utah
    Abstract: Improvement in GGT predicts event-free survival in primary sclerosing cholangitis regardless of ursodeoxycholic acid treatment: data from the Pediatric PSC Consortium

Resident Research Award (1 award)

The purpose of this $1,000 award is to recognize high quality research undertaken by a resident in training.

  • Varun Kesar, MBBS
    Institution: Lenox Hill Hospital, Northwell Health
    Abstract: Epidemiology of Severe HDS Induced DILI

Student Research Award (1 award)

This $1,000 award is given to a student who is the primary contributor to the research study in the abstract submitted to The Liver Meeting®.

  • Arvin Iracheta-Vellve, BS
    Institution: University of Massachusetts Medical School
    Abstract: Extracellular pro-inflammatory ASC ‘specks’ released by inflammasome-mediated pyroptosis to the circulation in alcoholic hepatitis and deposition of bioactive ASC oligomers in human and murine livers are biomarkers and mediators of alcoholic hepatitis

Young Investigator Travel Awards (20 awards)

These $1,000 awards enable young researchers submitting abstracts to The Liver Meeting® to receive travel support.

  • George Cholankeril, MD
    Institution: Stanford University School of Medicine
    Abstract: The Declining Burden of HCV on the Liver Transplant Waitlist associated with the DAA era
  • Asmita Choudhury, PhD
    Institution: University of Massachusetts Medical School
    Abstract: Heat Shock Transcription Factor 1 (HSF1), a key cellular proteostasis regulator, is crucial for resolution of liver fibrosis in mice
  • Maren H. Harms, MD
    Institution: Erasmus University Medical Center
    Abstract: Time Trends in Major Hepatic Complications in Primary Biliary Cholangitis: incidence and transplant-free survival
  • Chetan Ramesh Kalal, MD, DM
    Institution: Global Hospitals, Mumbai
    Abstract: To study efficacy of CRRT on ammonia clearance and mortality in the Acute liver Failure patients- A single centre observational study
  • Allison J. Kwong, MD
    Institution: Stanford University
    Abstract: Continued Increase in Incidence of De Novo Hepatocellular Carcinoma Among Liver Transplant Registrants with Hepatitis C Virus Infection
  • Brian P. Lee, MD
    Institution: University of California, San Francisco
    Abstract: Post-Transplant Outcomes from the Multi-Center American Consortium of Early Liver Transplantation for Alcoholic Hepatitis (ACCELERATE-AH) Study
  • Darrick K. Li, MD, PhD
    Institution: Massachusetts General Hospital
    Abstract: The incidence of hepatocellular carcinoma is not increased in individuals with chronic hepatitis C after SVR with interferon-free regimens compared with interferon-containing regimens: an ERCHIVES study
  • Anne Liu, MD
    Institution: Yale New Haven Hospital
    Abstract: A multicenter study revealing chronic hepatitis B comorbidity trends over the last 15 years in the United States
  • Matthew McMillin PhD
    Institution: Texas A&M University Health Science Center
    Abstract: Thrombospondin-1 Exacerbates Azoxymethane-Induced Acute Liver Injury and Hepatic Encephalopathy by Activating Transforming Growth Factor Beta 1 and Promoting Inflammation
  • Leah Norona, PhD
    Institution: University of North Carolina at Chapel Hill
    Abstract: Modeling compound-induced hepatic fibrosis in vitro using three-dimensional liver tissue constructs
  • Arti Pawaria, DM Pediatric Hepatology
    Institution: Institute of Liver and Biliary Sciences
    Abstract: Early Predictors of Mortality in Children with Acute Liver Failure with Jaundice to Encephalopathy Interval Less than 7 days
  • Cyriac Abby Philips, MD, DM
    Institution: Philip Augustine Associates, Ernakulam Medical Centre
    Abstract: Chemical and Toxicology Analysis of Ayurvedic and Herbal Drugs Causing Severe Liver Injury
  • Vikash Prakash, MBBS, MD, DM
    Institution: Institute of Liver and Biliary Sciences
    Abstract: Early introduction of a combination of low dose terlipressin and noradrenaline as vasopressors is superior to high dose noradrenaline alone in patients of cirrhosis with septic shock(NCT02468063)
  • Jeremy Rajanayagam, MBBS
    Institution: Royal Children's Hospital
    Abstract: Predictors of long-term normal histology on protocol allograft biopsies
  • Ann Robinson, MD
    Institution: Alameda Health System, Highland Hospital
    Abstract: Less Than Half of Hepatocellular Carcinoma Patients Among the 1945-1965 Birth Cohort in the U.S. Were Within Milan Criteria at Time of Diagnosis
  • Mai Sedki, MD
    Institution: University of Miami/Jackson Memorial Hospital
    Abstract: Comparison of Outcomes after DAA therapy among HCV-infected kidney transplant recipients who received grafts from either HCV-positive or negative donors
  • James E. Squires, MD, MS
    Institution: Children's Hospital of Pittsburgh
    Abstract: Liver Transplantation in Pediatric Acute Liver Failure (PALF): Practices and Patient Characteristics
  • Margo J.H. van Campenhout, MD
    Institution: Erasmus University Medical Center
    Abstract: Serum HBV RNA level predicts response to peginterferon add-on therapy for HBeAg-positive chronic hepatitis B
  • Adriaan van der Meer, MD, PhD
    Institution: Erasmus University Medical Center
    Abstract: Ursodeoxycholic Acid is Associated with a Prolonged Transplant-free Survival in All Patients with Primary Biliary Cholangitis – there is no such thing as non-response
  • Kellie Young, MD
    Institution: Santa Clara Valley Medical Center
    Abstract: Significantly Improved Liver Transplant Waitlist Survival Among Chronic Hepatitis C Virus Patients After Introduction of Direct Acting Antiviral Therapies

The Paul Angulo Travel Award for Best Abstract in Clinical NAFLD

Dr. Angulo was an exceptional clinical researcher who earned international prestige for his work on autoimmune and fatty liver disease. The goal of this $2,500 award is to encourage clinical research in non-alcoholic fatty liver disease.

  • Juna Konomi, PhD
    Institution: Emory University
    Abstract Title: Lipoprotein sub-fractions show increased cardiovascular disease risk in pediatric non-alcoholic steatohepatitis compared to non-alcoholic fatty liver

The Sherrie H. Cathcart Travel Award

This award is named in honor of Sherrie H. Cathcart for her many years of dedicated service as the Executive Director of the American Association for the Study of Liver Diseases. The goal of this $2,500 award is to inspire young investigators to present their research at The Liver Meeting®.

  • Harvey S. Chen, MD
    Institution: Mayo Clinic Rochester
    Abstract Title: Mayo Spheroid Reservoir Bio-Artificial Liver Improves Survival and Promotes Liver Regeneration in Post Hepatectomy ALF Pigs

The Professor Margit Hamosh Travel Award

This $2,500 award is presented to a fellow or junior investigator who submits the most outstanding abstract on hepatocellular carcinoma research for The Liver Meeting®.

  • Benyam D. Addissie, MD, MS
    Institution: Mayo Clinic Rochester
    Abstract Title: Proposal of GALADUS Score: Combining liver ultrasound with serum based biomarkers for Hepatocellular Carcinoma Surveillance

The Maribel Rodriguez-Torres Travel Award

Dr. Rodríguez -Torres was a renowned researcher and treater of HCV. She treated her patients with the utmost respect and care, and never gave up fighting for a cure for Hepatitis C. A pioneer for the latest treatments for HIV-HCV patients, Maribel dedicated her entire life to her work. The goal of this memorial $2,500 award is to encourage young investigators residing in Latin America or Spain in the area of Hepatitis C.

  • Marta Hernández Conde
    Institution: Hospital Universitario Puerta de Hierro
    Abstract Title: Effectiveness And Safety Of Elbasvir/Grazoprevir Treatment For HCV Patients In Real-Life Clinical Practice: Results From Spanish Hepa-C Cohort

The Leonard B. Seeff Award for Outstanding Research by a Young Investigator

This award is named in recognition of Dr. Leonard B. Seeff’s legacy as a leader in the field of hepatology, his commitment to training future leaders, and his many contributions to both hepatology and AASLD over the past half century. The goal of this $2,500 award is to inspire young investigators to present their research at The Liver Meeting®.

  • Yoon Mee Yang, PhD
    Institution: Cedars-Sinai Medical Center
    Abstract Title: Hepatic Stellate Cell-Derived Hyaluronan Synthase 2 Mediates Hyaluronic Acid Production That Promotes Liver Fibrosis

International Young Investigator Travel Award, in honor of Prof. C. Y. Kim

This award honors the lifetime commitment of Professor C. Y. Kim, whose pioneering work in the development of a Hepatitis B vaccine for Korea led to the tremendous advances in prevention of hepatitis in Koreans. This $1,500 award provides travel support to a young international researcher, residing in Korea, who has submitted a highly meritorious abstract for The Liver Meeting®.

  • Hyuk Soo Eun, MD, PhD
    Institution: Chungnam National University Hospital
    Abstract Title: Gene expression of the NOX family members and their clinical significance in hepatocellular carcinoma